Page 61 - Glass Machinery Plants & Accessories no. 4-2021
P. 61

mulated over many years as well   important asset to Nipro’s future   ny engaged in the medical field,
            as its state-of-the-art manufac-  and ambitious growth plans.      DMF was filed with the FDA in
            turing equipment and complete     Pharmaceutical glass packaging   1991 and a ISO 9002 certificate
            quality control.                  plays a crucial role in today’s   of approval was obtained in 1996
               In May 2021, Nipro Pharma      challenging world, especially in   -the first in Japan- for ampoule
            Packaging acquired Croatian       the wake of the COVID-19 pan-    and vial manufacturers.
            company Piramida - a manufac-     demic and the increased produc-    Abbott Diagnostics Medical Co.
            turer of glass packaging for the   tion of vaccines.               Ltd, Astellas Pharma Inc., Bristol-
            pharmaceutical industry.            “We want to continue to build   Myers Squibb Co. Ltd., Daiichi
               Established in 1950 and oper-  excellent customer relation-     Sankyo Co. Ltd, KYOWA CritiCare
            ating out of Sesvete near the     ships and become the preferred   Co. Ltd, Kaken Pharmaceutical
            Croatian capital Zagreb, Piramida   strategic partner to many phar-  Co. Ltd, Kyokuto Pharmaceutical
            produced more than half a bil-    maceutical companies,” said      Industrial Co. Ltd, Mochida
            lion ampoules and bottles for the   Stephan Arnold, CEO of Nipro   Pharmaceutical Co. Ltd, Nihon
            pharmaceutical industry in 2020.   PharmaPackaging International.  Pharmaceutical Co. Ltd. Nipro
            The company is ranked among                                        Corporation, Sato Pharmaceutical
            the top five largest ampoule man-  JAPAN GLASS INDUSTRY             Co. Ltd and Toa Pharmaceutical
            ufacturers for the pharmaceutical   CO. LTD                        Co. Ltd are just some of the phar-
            industry in the European market.    Japan Glass Industry Co. Ltd   maceutical glass containers con-
               With an outstanding market     has been offering exceptionally   sumers of Japan Glass Industry
            position in the Central European   safe medical containers - con-  Company.
            Territory, alongside an impec-    tributing to people’s health and
            cable reputation coupled with     happiness ever since its founding   SHIATONI GLASS
            sound and strong customer         in 1920. In order to maintain    COMPANY LTD
            relationships, Piramida is a very   the highest quality as a compa-  Established in 1930 at Nakatsu
                                                                               in Osaka to supply pharmaceuti-
                                                                               cal glass to Japan’s pharmaceuti-
                                                                               cal companies, Shiatoni Glass is
                                                                               one of the leading pharmaceuti-
                                                                               cal glass producers in Japan.

                                                                               NAGAI GLASS COMPANY
                                                                                 Osaka based Nagai Glass
                                                                               Company has been active in phar-
                                                                               maceutical glass production since
                                                                               1952. According to Nagai Glass’
                                                                               Keisuke Muratsu, “We have built
                                                                               the foundation of today through
                                                                               the establishment and develop-
                                                                               ment of mass production of one-
                                                                               point-cut ampoules and vials
                                                                               since the company was set up
                                                                               in 1951. With rapid subsequent
                                                                               innovation of technology, we’ve
                                                                               developed a lot of our own origi-
                                                                               nal forming machine and testing
                                                                               equipment and built up our sales
                                                                               performance by providing high-
                                                                               quality products. In recent years
                                                                               we’ve been working on the glo-
                                                                               balization of procurement of raw
                                                                               material, together with borosili-
                                                                               cate glass from the world’s major
                                                                               manufacturers. This fulfilled a
                                                                               system which meets a wide vari-
                                                                               ety of customer needs.”




                                                                                              GMP&A 4/2022  59
   56   57   58   59   60   61   62   63   64   65   66